<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 27, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03015363</url>
  </required_header>
  <id_info>
    <org_study_id>RS#: 2013-1919</org_study_id>
    <nct_id>NCT03015363</nct_id>
  </id_info>
  <brief_title>Clinical Calibration &amp; Validation of a Next-Generation Blood Pressure Monitor for Patient Management</brief_title>
  <acronym>CCV</acronym>
  <official_title>Comparison, Calibration, and Validation of the Non-invasive Cloud DX Pulsewave Health MonitorTM With Direct Invasive Radial and Central Arterial Measurements During Cardiac Catheterization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiovascular Research New Brunswick</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Horizon Health Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cloud Diagnostics, Incorporated</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New Brunswick Health Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardiovascular Research New Brunswick</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the Cloud DX Pulsewave Health Monitor study is to prospectively calibrate&#xD;
      and validate a novel, non-invasive wrist cuff blood pressure device against the gold standard&#xD;
      for hemodynamic monitoring (intra-arterial pressure) in voluntarily consented patient&#xD;
      participants who are scheduled for an elective cardiac catheterization procedure for&#xD;
      clinically valid reasons.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Cloud DX Pulsewave Health Monitor is a non-invasive wrist cuff blood pressure device that&#xD;
      is licensed by Health Canada with Food and Drug Administration approval. Systolic and&#xD;
      diastolic pressures are measured via the arterial pulse waveform of the left radial artery.&#xD;
      Initially, the blood pressure algorithm was created and calibrated using the auscultatory&#xD;
      method. The purpose of this study is to calibrate the device to the clinical gold standard of&#xD;
      peripheral and central intra-arterial pressures.&#xD;
&#xD;
      The device acquires a pulse signal in real-time, stores signal and measurement data, and&#xD;
      displays stored signal and measurement data for interpretation via internet servers where it&#xD;
      is accessible by end-users (physicians and/or patients). The system provides secure accounts&#xD;
      for both in-patient and out-patient monitoring. Cloud DX's Pulsewave Health Monitor servers&#xD;
      are housed in a secure data center. Privacy measures are to SSAE16 SOC-1 Type-II compliance:&#xD;
      1) restricted secure access, 2) dedicated firewall, 3) HTTPS channel communication via&#xD;
      website, 4) self-encrypting hard-drives rendered useless if removed from the server.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic pressure</measure>
    <time_frame>Simultaneous non-invasive blood pressure device and intra-arterial fluid-filled pressure catheter measurements on day of cardiac catheterization procedure.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Diastolic pressure</measure>
    <time_frame>Simultaneous non-invasive blood pressure device and intra-arterial fluid-filled pressure catheter measurements on day of cardiac catheterization procedure.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulse rate</measure>
    <time_frame>Non-invasive blood pressure device measurements on day of cardiac catheterization procedure.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breathing rate</measure>
    <time_frame>Non-invasive blood pressure device measurements on day of cardiac catheterization procedure.</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for an elective, non-emergent cardiac catheterization with right radial&#xD;
        access; exclusion criteria being no history of peripheral vascular disease, no previous&#xD;
        coronary artery bypass graft, no precious percutaneous coronary intervention, abdominal&#xD;
        aortic aneurysm, arrhythmia, hand/body tremor, nor bilateral arm pressure inequality during&#xD;
        history and physical.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 19 years of age&#xD;
&#xD;
          -  Patients recommended by their cardiologist for a first-time, elective cardiac&#xD;
             catheterization procedure&#xD;
&#xD;
          -  Wrist circumference between 13.5cm - 23cm (5.3 - 9.1in.)&#xD;
&#xD;
          -  Bilateral arm blood pressure equality (systolic within ±10mmHg; diastolic within&#xD;
             ±5mmHg) on 2 separate readings (Nurse Associate &amp; TRA)&#xD;
&#xD;
          -  Willing to volunteer to participate and to sign the study specific informed consent&#xD;
             form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No history of peripheral vascular disease, no previous percutaneous coronary&#xD;
             intervention, nor previous coronary artery bypass graft&#xD;
&#xD;
          -  No arrhythmia&#xD;
&#xD;
          -  No abdominal aortic aneurysm&#xD;
&#xD;
          -  No hand/body tremor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sohrab Lutchmedial, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular Research New Brunswick</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Horizon Health Network</name>
      <address>
        <city>Saint John</city>
        <state>New Brunswick</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.clouddx.com/</url>
    <description>Device company website</description>
  </link>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>January 5, 2017</study_first_submitted>
  <study_first_submitted_qc>January 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2017</study_first_posted>
  <last_update_submitted>February 16, 2018</last_update_submitted>
  <last_update_submitted_qc>February 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cardiovascular Research New Brunswick</investigator_affiliation>
    <investigator_full_name>Sohrab Lutchmedial, MD, FRCPC</investigator_full_name>
    <investigator_title>Co-Director of CVR-NB/ Director of NBHC Catheterization Laboratory</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Telemonitoring</keyword>
  <keyword>Vital signs</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

